Larson Yi 4
4 · Turning Point Therapeutics, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Larson Yi
EVP & Chief Financial Officer
Transactions
- Award
Common Stock
2021-02-08+4,617→ 7,321 total - Award
Stock Option (right to buy)
2021-02-08+20,775→ 20,775 totalExercise: $140.01Exp: 2031-02-07→ Common Stock (20,775 underlying)
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]1/48th of the shares vest monthly following February 8, 2021.